Abstract:The proton-induced electron-transfer reaction of a Cu(II) μ-thiolate complex to a Cu(I) -containing species has been investigated, both experimentally and computationally. The Cu(II) μ-thiolate complex [Cu(II) 2 (L(Me) S)2 ](2+) is isolated with the new pyridyl-containing ligand L(Me) SSL(Me) , which can form both Cu(II) thiolate and Cu(I) disulfide complexes, depending on the solvent. Both the Cu(II) and the Cu(I) complexes show reactivity upon addition of protons. The multivalent tetranuclear complex [Cu(I) … Show more
“…These ligands show similarities to the ligand LSSL, that has been shown to form a stable Cu II l-thiolate complex when reacted with Cu I (Fig. 1) [15,16].…”
“…These ligands show similarities to the ligand LSSL, that has been shown to form a stable Cu II l-thiolate complex when reacted with Cu I (Fig. 1) [15,16].…”
“…Addition of a methyl group next to the sulfur in the disulfide bond, however, results in significantly higher activity (entries [3][4][5][6]. Changing the bridge between the tertiary amine and the pyridyl groups from a methylene to an ethylene spacer at two positions leads to an increase in activity (entry 3 vs. 8), but at four positions it leads to a dramatic decrease in activity (entry 3 vs. 9).…”
Section: Dalton Transactions Papermentioning
confidence: 99%
“…After evaporation of the solvent, the product was treated with NaOH (50 mL; 5 M) and the aqueous layer was extracted with CHCl 3 (3 × 25 mL). The organic fractions were combined, dried over MgSO 4 8.0 mmol) and propylene sulfide (0.94 mL, 12.0 mmol) was stirred in 20 mL CH 3 CN at reflux temperature for 18 h under Ar atmosphere. The solvent was evaporated, after which the resulting oil was dissolved in 20 mL tetrahydrofuran.…”
Section: Ligand Synthesismentioning
confidence: 99%
“…The layers were separated and the aqueous layer was extracted two more times with 20 mL CH 2 Cl 2 . The combined organic layers were dried over Na 2 SO 4 …”
Section: Ligand Synthesismentioning
confidence: 99%
“…[1][2][3][4][5][6] It has been reported that small changes in the ligand structure can direct the reaction with copper salts towards the formation of either a Cu II µ-thiolate or a Cu I disulfide complex and that these species can interconvert (Fig. 1a).…”
A large library of Cu II complexes with mononucleating and dinucleating ligands was synthesized to investigate their potential as catalysts for the catalytic oxidation of 3,5-di-tert-butylcatechol (3,5-DTBC). X-ray structure determination for a number of these complexes revealed relatively large Cu⋯Cu distances and the formation of polymeric species. Comparison of the 3,5-DTBC oxidation rates showed that ligands that stabilize the biomimetic dinuclear Cu II µ-thiolate complex also result in copper compounds that are much more active in the oxidation of 3,5-DTBC. This oxidation activity is however inhibited by the presence of chloride ions. The highest k cat that was observed was 6900 h, which is one of the highest turnover frequencies reported so far for catechol oxidation in CH 3 CN.
In this study, some copper catalysts used for atom transfer radical polymerization (ATRP) were explored as efficient anti‐tumor agents. The aqueous solution of copper‐containing nanoparticles with uniform spheric morphology was in situ prepared through a copper‐catalyzed activator generated by electron transfer (AGET) ATRP in water. Nanoparticles were then directly injected into tumor‐bearing mice for antitumor chemotherapy. The copper nanodrugs had prolonged blood circulation time and enhanced accumulation at tumor sites, thus showing potent antitumor activity. This work provides a novel strategy for precise and large‐scale preparation of copper nanodrugs with high antitumor activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.